Recently, a strong inverse correlation was shown between adiponectin levels and the incidence of various malignant tumors, such as colorectal cancer, breast cancer, prostate cancer, leukemia, and endometrial cancer. This evidence concerns the gene ADIPOQ and endometrial cancer.